{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["41(8)"],"submitter":["Baral R"],"funding":["Global Fund to Fight AIDS, Tuberculosis and Malaria","World Health Organization"],"pubmed_abstract":["<h4>Background</h4>The World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children residing in regions of moderate to high malaria transmission. This recommendation is informed by RTS,S evidence, including findings from the pilot rollout of the vaccine in Ghana, Kenya, and Malawi. This study estimates the incremental costs of introducing and delivering the malaria vaccine within routine immunization programs in the context of malaria vaccine pilot introduction, to help inform decision-making.<h4>Methods</h4>An activity-based, retrospective costing was conducted from the governments' perspective. Vaccine introduction and delivery costs supported by the donors during the pilot introduction were attributed as costs to the governments und"],"journal":["Vaccine"],"pagination":["1496-1502"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9946791"],"repository":["biostudies-literature"],"pubmed_title":["Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program."],"pmcid":["PMC9946791"],"pubmed_authors":["Levin A","Mkisi R","Chisema MN","Baral R","Odero C","Gordon S","Pecenka C","Muhib F","Amponsa-Achaino K","Eddah Jalango R","Morgan W","Antwi-Agyei KO","Tanko Bawa J"],"additional_accession":[]},"is_claimable":false,"name":"Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program.","description":"<h4>Background</h4>The World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children residing in regions of moderate to high malaria transmission. This recommendation is informed by RTS,S evidence, including findings from the pilot rollout of the vaccine in Ghana, Kenya, and Malawi. This study estimates the incremental costs of introducing and delivering the malaria vaccine within routine immunization programs in the context of malaria vaccine pilot introduction, to help inform decision-making.<h4>Methods</h4>An activity-based, retrospective costing was conducted from the governments' perspective. Vaccine introduction and delivery costs supported by the donors during the pilot introduction were attributed as costs to the governments und","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-19T00:56:24.515Z","creation":"2025-04-07T11:55:09.52Z"},"accession":"S-EPMC9946791","cross_references":{"pubmed":["36710234"],"doi":["10.1016/j.vaccine.2023.01.043"]}}